Novavax Readies Its Vaccine to Fight Covid Worldwide

Novavax had no sales to report for its June quarter. But the Gaithersburg, Md.-based firm’s vaccine has done so well in clinical trials against the Covid-19 virus that its Thursday report on the quarter looked confidently ahead to the authorizations it expects from governments around the world.

SECRET SOFTWARE SHOWS WHEN TO

BUY OR SELL!

TRADE WITH CONFIDENCE

Stock SignalsStock Signals

With studies showing its shots to be more than 90% effective at preventing Covid, even from worrisome virus variants, Novavax (ticker: NVAX) stock doubled this year to a Thursday close of $236.20. The shares were off 10%, to $212, in…

Share:

Author: admin

StockMarketLeakz.com

Leave a Reply